title: Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates.
authors.affiliation: Clinical Drug Development, Novo Nordisk A/S, Bagsvaerd, Denmark.
authors.forename: W
authors.initials: W
authors.lastname: Streif
authors.forename: R
authors.initials: R
authors.lastname: Borum Andreasen
authors.forename: B
authors.initials: B
authors.lastname: Paes
authors.forename: L
authors.initials: L
authors.lastname: Berry
authors.forename: L
authors.initials: L
authors.lastname: Xu
authors.forename: M
authors.initials: M
authors.lastname: Andrew
authors.forename: A K
authors.initials: AK
authors.lastname: Chan
mesh_terms: D015942:Factor VIIa / Q000494:pharmacology*; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D013917:Thrombin / Q000096:biosynthesis*
chemical_list: D015942:Factor VIIa; D013917:Thrombin